TABLE 3.
Univariate and multivariable Cox regression of TK1 expression for progression-free survival in PCa patients.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | ||
| Age | 499 | ||||
| ≤60 | 224 | Reference | |||
| >60 | 275 | 1.302 (0.863-1.963) | 0.208 | ||
| T stage | 492 | ||||
| T2 | 189 | Reference | |||
| T3&T4 | 303 | 3.785 (2.140-6.693) | <0.001 | 1.442 (0.690-3.017) | 0.331 |
| N stage | 426 | ||||
| N0 | 347 | Reference | |||
| N1 | 79 | 1.946 (1.202-3.150) | 0.007 | 0.812 (0.463-1.423) | 0.466 |
| M stage | 458 | ||||
| M0 | 455 | Reference | |||
| M1 | 3 | 3.566 (0.494-25.753) | 0.208 | ||
| Gleason score | 499 | ||||
| 6&7&8 | 357 | Reference | |||
| 9&10 | 142 | 4.590 (3.038-6.934) | <0.001 | 2.040 (1.160-3.588) | 0.013 |
| Primary therapy outcome | 438 | ||||
| PD&SD&PR | 97 | Reference | |||
| CR | 341 | 0.151 (0.099-0.231) | <0.001 | 0.283 (0.161-0.499) | <0.001 |
| Residual tumor | 468 | ||||
| R0 | 315 | Reference | |||
| R1&R2 | 153 | 2.365 (1.566-3.570) | <0.001 | 1.041 (0.609-1.781) | 0.883 |
| PSA (ng/ml) | 442 | ||||
| <4 | 415 | Reference | |||
| ≥4 | 27 | 4.196 (2.095-8.405) | <0.001 | 1.990 (0.894-4.432) | 0.092 |
| TK1 | 499 | 1.862 (1.506-2.302) | <0.001 | 1.486 (1.119-1.975) | 0.006 |